Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Provident Bancorp, Inc.
14.8% sales growth and 5.45% return on equity
Provident Bancorp, Inc. operates as a holding company for The Provident Bank that provides various financial services to individuals and small businesses in the United States.
Provident Bancorp, Inc. sales growth this year is anticipated to be 23% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 47.86M for the twelve trailing months.
Provident Bancorp, Inc.'s sales growth for the next quarter is 14.8%. The company's growth estimates for the present quarter and the next is 35.7% and 57.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.45%.
Provident Bancorp, Inc.'s Stock Top and Bottom Yearly Value
Provident Bancorp, Inc.'s stock is valued at $11.48 at 17:57 EST, way below its 52-week high of $12.92 and way higher than its 52-week low of $7.21.
Provident Bancorp, Inc.'s Moving Average
Provident Bancorp, Inc.'s value is way higher than its 50-day moving average of $9.44 and way higher than its 200-day moving average of $8.43.2. BMC Stock Holdings, Inc.
12.8% sales growth and 12.69% return on equity
BMC Stock Holdings, Inc., together with its subsidiaries, provides various building products and services for homebuilder and professional contractor customers in the United States.
BMC Stock Holdings, Inc. sales growth this year is anticipated to be 14.2% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 3.88B for the twelve trailing months.
BMC Stock Holdings, Inc.'s sales growth for the next quarter is 12.8%. The company's growth estimates for the current quarter and the next is 86.5% and 45%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.69%.
BMC Stock Holdings, Inc.'s Stock Top and Bottom Yearly Value
BMC Stock Holdings, Inc.'s stock is valued at $46.17 at 17:57 EST, under its 52-week high of $50.26 and way above its 52-week low of $13.38.
BMC Stock Holdings, Inc.'s Moving Average
BMC Stock Holdings, Inc.'s worth is above its 50-day moving average of $44.70 and way higher than its 200-day moving average of $35.17.3. Franklin Resources, Inc.
42.3% sales growth and 6.88% return on equity
Franklin Resources, Inc. is a publicly owned asset management holding company.
Franklin Resources, Inc. sales growth this year is expected to be 32.4% and a negative 0.3% for next year.
Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 5.57B for the twelve trailing months.
Franklin Resources, Inc.'s sales growth for the next quarter is 42.3%. The company's growth estimates for the current quarter and the next is 4.5% and 6.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.88%.
Franklin Resources, Inc.'s Stock Top and Bottom Yearly Value
Franklin Resources, Inc.'s stock is valued at $23.98 at 17:57 EST, way under its 52-week high of $27.60 and way higher than its 52-week low of $14.91.
Franklin Resources, Inc.'s Moving Average
Franklin Resources, Inc.'s value is way above its 50-day moving average of $21.34 and way higher than its 200-day moving average of $21.26.4. Seattle Genetics, Inc.
60.8% sales growth and 23.4% return on equity
Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally.
Seattle Genetics, Inc. sales growth this year is anticipated to be 134.9% and a negative 16.8% for next year.
Year-on-year quarterly revenue growth grew by 397.9%, now sitting on 1.86B for the twelve trailing months.
Seattle Genetics, Inc.'s sales growth for the next quarter is 60.8%. The company's growth estimates for the ongoing quarter and the next is 478.6% and 72.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.4%.
Seattle Genetics, Inc.'s Stock Top and Bottom Yearly Value
Seattle Genetics, Inc.'s stock is valued at $179.23 at 17:57 EST, way under its 52-week high of $213.94 and way above its 52-week low of $90.57.
Seattle Genetics, Inc.'s Moving Average
Seattle Genetics, Inc.'s value is below its 50-day moving average of $179.74 and higher than its 200-day moving average of $171.22.5. XP Inc.
47% sales growth and 32.64% return on equity
XP Inc. operates technology-driven financial services platform that provides financial products and services in Brazil.
XP Inc. sales growth this year is anticipated to be 66.1% and 37.6% for next year.
Year-on-year quarterly revenue growth grew by 54.9%, now sitting on N/A for the twelve trailing months.
XP Inc.'s sales growth for the next quarter is 47%. The company's growth estimates for the ongoing quarter and the next is 33.3% and 42.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.64%.
XP Inc.'s Stock Top and Bottom Yearly Value
XP Inc.'s stock is valued at $37.93 at 17:57 EST, way under its 52-week high of $52.94 and way higher than its 52-week low of $15.50.